Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Equity (2016 - 2025)

Historic Return on Equity for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to 0.04%.

  • OptimizeRx's Return on Equity rose 3100.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 0.13% for FY2024, which is 100.0% up from last year.
  • Per OptimizeRx's latest filing, its Return on Equity stood at 0.04% for Q3 2025, which was up 3100.0% from 0.04% recorded in Q2 2025.
  • OptimizeRx's 5-year Return on Equity high stood at 0.04% for Q3 2025, and its period low was 0.27% during Q3 2024.
  • For the 5-year period, OptimizeRx's Return on Equity averaged around 0.09%, with its median value being 0.09% (2022).
  • In the last 5 years, OptimizeRx's Return on Equity crashed by -1500bps in 2024 and then skyrocketed by 3100bps in 2025.
  • Over the past 5 years, OptimizeRx's Return on Equity (Quarter) stood at 0.0% in 2021, then plummeted by -3155bps to 0.09% in 2022, then plummeted by -132bps to 0.21% in 2023, then surged by 36bps to 0.13% in 2024, then skyrocketed by 130bps to 0.04% in 2025.
  • Its Return on Equity was 0.04% in Q3 2025, compared to 0.04% in Q2 2025 and 0.09% in Q1 2025.